June 16, 2020 / 7:56 PM / 19 days ago

BRIEF-FDA Approves Ilaris Injection For Treatment Of Adult Onset Still's Disease

June 16 (Reuters) - U.S. FDA :

* FDA APPROVES FIRST TREATMENT FOR ADULT ONSET STILL’S DISEASE, A SEVERE AND RARE DISEASE

* FDA - APPROVED ILARIS INJECTION FOR TREATMENT OF ACTIVE STILL’S DISEASE, INCLUDING ADULT-ONSET STILL’S DISEASE

* FDA - APPROVAL OF ILARIS WAS GRANTED TO NOVARTIS PHARMACEUTICALS CORPORATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below